CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker von Landras, Alexandra, Reger de Moura, Coralie, Jouenne, Fanelie, Lebbe, Celeste, Menashi, Suzanne, Mourah, Samia

Volltext

Atypical BRAF and NRAS Mutations in Mucosal Melanoma von Dumaz, Nicolas, Jouenne, Fanélie, Delyon, Julie, Mourah, Samia, Bensussan, Armand, Lebbé, Céleste

Volltext

Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review von Gauci, Marie-Léa, Laly, Pauline, Vidal-Trecan, Tiphaine, Baroudjian, Barouyr, Gottlieb, Jérémy, Madjlessi-Ezra, Nika, Da Meda, Laetitia, Madelaine-Chambrin, Isabelle, Bagot, Martine, Basset-Seguin, Nicole, Pages, Cécile, Mourah, Samia, Boudou, Philippe, Lebbé, Céleste, Gautier, Jean-François

Volltext

NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi von Charbel, Christelle, Fontaine, Romain H., Malouf, Gabriel G., Picard, Arnaud, Kadlub, Natacha, El-Murr, Nizar, How-Kit, Alexandre, Su, Xiaoping, Coulomb-L'Hermine, Aurore, Tost, Jorg, Mourah, Samia, Aractingi, Selim, Guégan, Sarah

Volltext

Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction von Landras, Alexandra, Reger de Moura, Coralie, Villoutreix, Bruno O., Battistella, Maxime, Sadoux, Aurélie, Dumaz, Nicolas, Menashi, Suzanne, Fernández-Recio, Juan, Lebbé, Céleste, Mourah, Samia

Volltext

Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-... von Vignal, Nicolas, Kelly, Loïs, Lengline, Etienne, Cabannes-Hamy, Aurélie, Siavellis, Justine, Ghez, David, Sauvageon, Hélène, Braun, Thorsten, Jacqz-Aigrain, Evelyne, Kohn, Milena, Rousselot, Philippe, Puissant, Alexandre, Raffoux, Emmanuel, Mourah, Samia, Goldwirt, Lauriane

Volltext

Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study) von Leroy, Karen, Audigier Valette, Clarisse, Alexandre, Jérôme, Boussemart, Lise, Chiesa, Jean, Deldycke, Clotilde, Gomez-Rocca, Carlos, Hollebecque, Antoine, Lehmann-Che, Jacqueline, Lemoine, Antoinette, Mansard, Sandrine, Medioni, Jacques, Monnet, Isabelle, Mourah, Samia, Pierret, Thomas, Spaëth, Dominique, Civet, Alexandre, Galoin, Sandrine, Italiano, Antoine

Volltext

Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature von Rémond, Maxime, Pachev, Atanas, Battistella, Maxime, Gandon, Camille, Mourah, Samia, Madelaine, Isabelle, Maggiori, Léon, Benadon, Bethsabée, Hammoudi, Nassim, Lourenço, Nelson, Aparicio, Thomas

Volltext

Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia von Puisset, Florent, Raffoux, Emmanuel, Ades, Lionel, Huynh, Tony, Itzykson, Raphaël, Bouscary, Didier, Aguinana, Loréa, Rabian, Florence, Sebert, Marie, Vekhoff, Anne, Brissot, Eolia, Mohty, Mohamad, Bonnin, Agnes, Genthon, Alexis, Zerbit, Jeremie, Willems, Lise, Decrocq, Justine, Contejean, Adrien, Lengline, Etienne, Mourah, Samia, Goldwirt, Lauriane

Volltext

ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors von Richard, Geoffrey, Dalle, Stéphane, Monet, Marie‐Ambre, Ligier, Maud, Boespflug, Amélie, Pommier, Roxane M, de la Fouchardière, Arnaud, Perier‐Muzet, Marie, Depaepe, Lauriane, Barnault, Romain, Tondeur, Garance, Ansieau, Stéphane, Thomas, Emilie, Bertolotto, Corine, Ballotti, Robert, Mourah, Samia, Battistella, Maxime, Lebbé, Céleste, Thomas, Luc, Puisieux, Alain, Caramel, Julie

Volltext

PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors von Delyon, Julie, Becherirat, Selma, Roger, Anissa, Bernard-Cacciarella, Mélanie, Reger De Moura, Coralie, Louveau, Baptiste, Mourah, Samia, Lebbé, Céleste, Dumaz, Nicolas

Volltext

Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK von Oulès, Bénédicte, Mourah, Samia, Baroudjian, Barouyr, Jouenne, Fanélie, Delyon, Julie, Louveau, Baptiste, Gruber, Aurélia, Lebbé, Céleste, Battistella, Maxime

Volltext

A Novel Case of Gorlin Syndrome Mosaicism Involving an SMO Gene Mutation: Clinical, Histological and Molecular Analysis of Basaloid Tumours von Ighilahriz, Meriem, Nikolaev, Sergey, Yurchenko, Andrey A, Battistella, Maxime, Mourah, Samia, Jouenne, Fanélie, Bourrat, Emanuelle, Basset-Seguin, Nicole

Volltext

Efficacy of ibrutinib in the treatment of Bing–Neel syndrome von Cabannes‐Hamy, Aurélie, Lemal, Richard, Goldwirt, Lauriane, Poulain, Stéphanie, Amorim, Sandy, Pérignon, Renan, Berger, Juliette, Brice, Pauline, De Kerviler, Eric, Bay, Jacques‐Olivier, Sauvageon, Helene, Beldjord, Kheira, Mourah, Samia, Tournilhac, Olivier, Thieblemont, Catherine

Volltext

Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma von Hurabielle, Charlotte, Pillebout, Evangéline, Stehlé, Thomas, Pagès, Cécile, Roux, Jennifer, Schneider, Pierre, Chevret, Sylvie, Chaffaut, Cendrine, Boutten, Anne, Mourah, Samia, Basset-Seguin, Nicole, Vidal-Petiot, Emmanuelle, Lebbé, Céleste, Flamant, Martin

Volltext

Erratum to ‘Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin’ [EJC Skin Cancer 1 (2023) 100002] von Bellahsen-Harrar, Yaëlle, Boisson, Marie, Louveau, Baptiste, Baroudjian, Barouyr, Aparicio, Thomas, Ferré, Valentine, Parc, Yann, Sadoux, Aurélie, Jouenne, Fanélie, Battistella, Maxime, Lebbé, Céleste, Mourah, Samia

Volltext

Ultrasensitive detection and identification of BRAF V600 mutations in fresh frozen, FFPE, and plasma samples of melanoma patients by E-ice-COLD-PCR von How-Kit, Alexandre, Lebbé, Céleste, Bousard, Aurélie, Daunay, Antoine, Mazaleyrat, Nicolas, Daviaud, Christian, Mourah, Samia, Tost, Jörg

Volltext

Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance von Reger de Moura, Coralie, Prunotto, Marco, Sohail, Anjum, Battistella, Maxime, Jouenne, Fanelie, Marbach, Daniel, Lebbé, Celeste, Fridman, Rafael, Mourah, Samia

Volltext

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma von Reger de Moura, Coralie, Vercellino, Laetitia, Jouenne, Fanélie, Baroudjian, Barouyr, Sadoux, Aurélie, Louveau, Baptiste, Delyon, Julie, Serror, Kevin, Goldwirt, Lauriane, Merlet, Pascal, Bouquet, Fanny, Battistella, Maxime, Lebbé, Céleste, Mourah, Samia

Volltext

Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (IN... von Mourah, Samia, Denis, Marc G, Narducci, Fabienne Escande, Solassol, Jérôme, Merlin, Jean-Louis, Sabourin, Jean-Christophe, Scoazec, Jean-Yves, Ouafik, L'Houcine, Emile, Jean-François, Heller, Remy, Souvignet, Claude, Bergougnoux, Loïc, Merlio, Jean-Philippe

Volltext